Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hoxa2
|
ENSMUSG00000014704.8 | homeobox A2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr6_52165009_52165376 | Hoxa2 | 361 | 0.461491 | 0.68 | 1.0e-08 | Click! |
chr6_52164761_52164938 | Hoxa2 | 18 | 0.890983 | 0.65 | 6.4e-08 | Click! |
chr6_52163698_52164573 | Hoxa2 | 696 | 0.334192 | 0.57 | 4.4e-06 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr13_112695608_112695943 | 41.61 |
Gm18883 |
predicted gene, 18883 |
3904 |
0.16 |
chr16_17987771_17988057 | 39.52 |
Vpreb2 |
pre-B lymphocyte gene 2 |
7486 |
0.13 |
chr6_17796921_17797464 | 32.78 |
Gm26738 |
predicted gene, 26738 |
37993 |
0.12 |
chr9_29523209_29523462 | 31.27 |
Gm15521 |
predicted gene 15521 |
69175 |
0.13 |
chr9_110053315_110053992 | 31.06 |
Map4 |
microtubule-associated protein 4 |
1601 |
0.28 |
chr1_14513900_14514131 | 30.74 |
Eya1 |
EYA transcriptional coactivator and phosphatase 1 |
203780 |
0.02 |
chr3_146101045_146101508 | 23.95 |
Wdr63 |
WD repeat domain 63 |
6854 |
0.16 |
chr6_94773287_94774569 | 23.06 |
Gm43997 |
predicted gene, 43997 |
25504 |
0.15 |
chr6_36776057_36776246 | 22.93 |
Ptn |
pleiotrophin |
34028 |
0.2 |
chr6_142835752_142836097 | 22.73 |
Gm7457 |
predicted gene 7457 |
21539 |
0.16 |
chr10_92162409_92163019 | 22.41 |
Rmst |
rhabdomyosarcoma 2 associated transcript (non-coding RNA) |
47 |
0.98 |
chr3_127874309_127874632 | 22.24 |
Gm43652 |
predicted gene 43652 |
10612 |
0.11 |
chr12_44462981_44463367 | 22.19 |
Nrcam |
neuronal cell adhesion molecule |
6514 |
0.25 |
chr18_54282245_54282440 | 21.61 |
Redrum |
Redrum, erythroid developmental long intergenic non-protein coding transcript |
139953 |
0.05 |
chr3_83789572_83790373 | 21.45 |
Gm26771 |
predicted gene, 26771 |
16 |
0.97 |
chr12_49945819_49946221 | 21.29 |
Gm7481 |
predicted gene 7481 |
104269 |
0.08 |
chr9_89496663_89497009 | 21.20 |
Gm47403 |
predicted gene, 47403 |
63548 |
0.11 |
chr16_77759859_77760395 | 21.11 |
Gm37694 |
predicted gene, 37694 |
74850 |
0.07 |
chr1_74103754_74104304 | 21.00 |
Tns1 |
tensin 1 |
5353 |
0.18 |
chr3_137680957_137681359 | 20.78 |
Gm21962 |
predicted gene, 21962 |
9634 |
0.14 |
chr2_115631313_115631464 | 20.54 |
Mir1951 |
microRNA 1951 |
7337 |
0.24 |
chr7_121622954_121623277 | 19.80 |
4933432K03Rik |
RIKEN cDNA 4933432K03 gene |
13781 |
0.18 |
chr13_83749525_83749738 | 19.56 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
10768 |
0.12 |
chr9_91365711_91366045 | 19.42 |
Zic1 |
zinc finger protein of the cerebellum 1 |
68 |
0.95 |
chr5_109556763_109557843 | 19.41 |
Crlf2 |
cytokine receptor-like factor 2 |
830 |
0.53 |
chr5_54158308_54158653 | 19.29 |
Stim2 |
stromal interaction molecule 2 |
42623 |
0.18 |
chr19_18902180_18902747 | 19.19 |
Trpm6 |
transient receptor potential cation channel, subfamily M, member 6 |
61826 |
0.13 |
chr10_28366185_28366336 | 18.39 |
Gm22370 |
predicted gene, 22370 |
152139 |
0.04 |
chr2_70126625_70126776 | 18.34 |
Myo3b |
myosin IIIB |
30402 |
0.2 |
chr13_107541201_107541459 | 18.22 |
Gm32004 |
predicted gene, 32004 |
23993 |
0.2 |
chr8_26420618_26420920 | 18.08 |
Gm31898 |
predicted gene, 31898 |
14944 |
0.16 |
chr4_143045184_143045590 | 18.01 |
6330411D24Rik |
RIKEN cDNA 6330411D24 gene |
28379 |
0.19 |
chr4_33524476_33525134 | 17.96 |
Gm11935 |
predicted gene 11935 |
71916 |
0.1 |
chr18_42644502_42645243 | 17.61 |
C030004G16Rik |
RIKEN cDNA C030004G16 gene |
22413 |
0.16 |
chr13_73070260_73070539 | 17.58 |
Rpl31-ps2 |
ribosomal protein L31, pseudogene 2 |
162996 |
0.03 |
chr3_109561341_109561658 | 17.47 |
Vav3 |
vav 3 oncogene |
12408 |
0.3 |
chr15_11083019_11083430 | 17.31 |
Adamts12 |
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 12 |
18406 |
0.2 |
chr3_86857906_86858095 | 17.27 |
Gm37025 |
predicted gene, 37025 |
6492 |
0.21 |
chr6_109874355_109874582 | 17.20 |
Gm44162 |
predicted gene, 44162 |
158921 |
0.04 |
chr1_42691969_42692512 | 16.86 |
Pantr1 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 1 |
853 |
0.48 |
chr5_16002604_16003015 | 16.84 |
Gm43000 |
predicted gene 43000 |
4970 |
0.22 |
chr2_153425549_153426538 | 16.51 |
Gm14472 |
predicted gene 14472 |
12194 |
0.16 |
chr10_57784462_57784659 | 16.48 |
Fabp7 |
fatty acid binding protein 7, brain |
321 |
0.86 |
chr11_30266924_30267397 | 16.43 |
Sptbn1 |
spectrin beta, non-erythrocytic 1 |
54 |
0.81 |
chr1_38545629_38545887 | 16.32 |
Gm34727 |
predicted gene, 34727 |
58239 |
0.13 |
chr4_72800139_72800290 | 16.26 |
Aldoart1 |
aldolase 1 A, retrogene 1 |
52418 |
0.16 |
chr19_24845004_24845349 | 16.23 |
Gm50342 |
predicted gene, 50342 |
11020 |
0.16 |
chr14_46647395_46647602 | 16.21 |
4933425B07Rik |
RIKEN cDNA 4933425B07 gene |
10075 |
0.11 |
chr13_84783122_84783632 | 16.03 |
Gm26913 |
predicted gene, 26913 |
92436 |
0.09 |
chr3_35405107_35405293 | 16.00 |
Gm43078 |
predicted gene 43078 |
8633 |
0.26 |
chr16_91962945_91963627 | 15.93 |
Gm27773 |
predicted gene, 27773 |
19138 |
0.1 |
chr14_22505891_22506190 | 15.91 |
4930405A10Rik |
RIKEN cDNA 4930405A10 gene |
36758 |
0.18 |
chr15_88036655_88037015 | 15.91 |
Gm35772 |
predicted gene, 35772 |
36909 |
0.2 |
chr3_97334639_97334971 | 15.89 |
Bcl9 |
B cell CLL/lymphoma 9 |
36888 |
0.15 |
chr2_47334845_47334996 | 15.82 |
Gm25959 |
predicted gene, 25959 |
207064 |
0.03 |
chr10_52940614_52940777 | 15.82 |
Gm25664 |
predicted gene, 25664 |
35057 |
0.19 |
chr9_75610077_75610239 | 15.74 |
Tmod2 |
tropomodulin 2 |
917 |
0.49 |
chr2_106193854_106194042 | 15.73 |
Dcdc5 |
doublecortin domain containing 5 |
28109 |
0.21 |
chr5_9726061_9726270 | 15.53 |
Grm3 |
glutamate receptor, metabotropic 3 |
995 |
0.6 |
chr15_67898912_67899432 | 15.31 |
Gm49408 |
predicted gene, 49408 |
25344 |
0.23 |
chr1_25893085_25893254 | 15.30 |
Gm9884 |
predicted gene 9884 |
62512 |
0.08 |
chr19_15340816_15341006 | 15.24 |
Gm24319 |
predicted gene, 24319 |
339093 |
0.01 |
chr13_84569455_84569857 | 15.22 |
Gm26913 |
predicted gene, 26913 |
121285 |
0.06 |
chr3_34559225_34559387 | 15.13 |
Sox2ot |
SOX2 overlapping transcript (non-protein coding) |
1022 |
0.48 |
chr10_122887491_122888199 | 15.08 |
Ppm1h |
protein phosphatase 1H (PP2C domain containing) |
7523 |
0.23 |
chr15_8659416_8659937 | 15.05 |
Gm37310 |
predicted gene, 37310 |
4603 |
0.23 |
chr11_19531256_19531439 | 15.04 |
Gm12027 |
predicted gene 12027 |
96714 |
0.08 |
chr16_64069361_64069662 | 15.04 |
Gm49627 |
predicted gene, 49627 |
114381 |
0.07 |
chr9_102193238_102193748 | 15.02 |
Gm37945 |
predicted gene, 37945 |
20755 |
0.17 |
chr3_88230737_88231417 | 15.01 |
Gm3764 |
predicted gene 3764 |
2294 |
0.13 |
chr10_109888816_109888986 | 15.01 |
Nav3 |
neuron navigator 3 |
15122 |
0.28 |
chr17_43952161_43952315 | 14.81 |
Rcan2 |
regulator of calcineurin 2 |
761 |
0.77 |
chr18_62863041_62863580 | 14.74 |
Gm50128 |
predicted gene, 50128 |
58791 |
0.11 |
chr15_7126432_7126583 | 14.74 |
Lifr |
LIF receptor alpha |
3052 |
0.36 |
chr4_86069459_86069836 | 14.72 |
Adamtsl1 |
ADAMTS-like 1 |
15627 |
0.24 |
chr2_101172759_101173110 | 14.66 |
Gm20693 |
predicted gene 20693 |
397690 |
0.01 |
chr11_32001599_32001931 | 14.61 |
Nsg2 |
neuron specific gene family member 2 |
1263 |
0.5 |
chr12_51000444_51000673 | 14.55 |
Gm40421 |
predicted gene, 40421 |
4315 |
0.24 |
chr9_40268412_40269319 | 14.43 |
Scn3b |
sodium channel, voltage-gated, type III, beta |
352 |
0.82 |
chr2_95232148_95232706 | 14.43 |
Gm13794 |
predicted gene 13794 |
161815 |
0.04 |
chr5_19907432_19907665 | 14.42 |
Magi2 |
membrane associated guanylate kinase, WW and PDZ domain containing 2 |
30 |
0.99 |
chr4_75562472_75562807 | 14.42 |
Gm11259 |
predicted gene 11259 |
181879 |
0.03 |
chr1_166948095_166948312 | 14.38 |
Gm6286 |
predicted gene 6286 |
1845 |
0.39 |
chr13_107546341_107546492 | 14.32 |
Gm32004 |
predicted gene, 32004 |
18907 |
0.21 |
chr14_119582119_119582270 | 14.31 |
Gm6212 |
predicted gene 6212 |
61818 |
0.14 |
chr17_73507966_73508157 | 14.30 |
AC107792.1 |
Novel transcript |
9694 |
0.17 |
chr7_51662439_51662822 | 14.30 |
Gm45072 |
predicted gene 45072 |
30905 |
0.14 |
chr3_88206531_88206915 | 14.29 |
Gm3764 |
predicted gene 3764 |
90 |
0.91 |
chr2_33543695_33544688 | 14.27 |
Gm13530 |
predicted gene 13530 |
54409 |
0.1 |
chr9_102235369_102235971 | 14.22 |
Gm37260 |
predicted gene, 37260 |
38066 |
0.14 |
chr2_145971661_145971990 | 14.22 |
Crnkl1 |
crooked neck pre-mRNA splicing factor 1 |
36811 |
0.14 |
chr6_55921320_55921515 | 14.17 |
Itprid1 |
ITPR interacting domain containing 1 |
34592 |
0.21 |
chr6_29023677_29023877 | 14.13 |
Mir129-1 |
microRNA 129-1 |
1158 |
0.48 |
chr5_74905641_74905990 | 14.08 |
Gm17906 |
predicted gene, 17906 |
22480 |
0.17 |
chr12_80759665_80760570 | 14.04 |
Ccdc177 |
coiled-coil domain containing 177 |
570 |
0.61 |
chr8_70315603_70316677 | 14.03 |
Cers1 |
ceramide synthase 1 |
353 |
0.75 |
chr1_162346730_162346881 | 13.98 |
Gm16101 |
predicted gene 16101 |
30713 |
0.16 |
chr11_33670175_33670394 | 13.94 |
Kcnip1 |
Kv channel-interacting protein 1 |
10287 |
0.18 |
chr13_96130906_96131482 | 13.92 |
Sv2c |
synaptic vesicle glycoprotein 2c |
1383 |
0.35 |
chr10_105318965_105319162 | 13.70 |
Gm48206 |
predicted gene, 48206 |
21186 |
0.19 |
chr4_13796808_13797041 | 13.70 |
Runx1t1 |
RUNX1 translocation partner 1 |
12142 |
0.29 |
chr18_25661760_25662086 | 13.67 |
0710001A04Rik |
RIKEN cDNA 0710001A04 gene |
51847 |
0.14 |
chr3_11261156_11261347 | 13.63 |
Gm22547 |
predicted gene, 22547 |
106914 |
0.08 |
chr5_111944379_111944557 | 13.62 |
Gm42488 |
predicted gene 42488 |
233 |
0.96 |
chr10_25112532_25112706 | 13.57 |
Gm22566 |
predicted gene, 22566 |
58479 |
0.1 |
chr6_101198204_101198658 | 13.56 |
Gm26911 |
predicted gene, 26911 |
138 |
0.9 |
chr4_72382387_72382548 | 13.55 |
Gm11235 |
predicted gene 11235 |
160199 |
0.04 |
chr8_25392912_25393353 | 13.51 |
Gm39147 |
predicted gene, 39147 |
5888 |
0.16 |
chr13_110280472_110281172 | 13.49 |
Rab3c |
RAB3C, member RAS oncogene family |
79 |
0.98 |
chr14_75473590_75473918 | 13.49 |
Siah3 |
siah E3 ubiquitin protein ligase family member 3 |
17772 |
0.22 |
chr3_88239048_88239748 | 13.48 |
Gm3764 |
predicted gene 3764 |
10615 |
0.07 |
chr12_116641726_116642225 | 13.47 |
Gm17807 |
predicted gene, 17807 |
44722 |
0.16 |
chr6_103511969_103512187 | 13.41 |
Chl1 |
cell adhesion molecule L1-like |
748 |
0.64 |
chr2_38621601_38621752 | 13.41 |
Gm13586 |
predicted gene 13586 |
1125 |
0.39 |
chr3_80803394_80803569 | 13.39 |
Gria2 |
glutamate receptor, ionotropic, AMPA2 (alpha 2) |
646 |
0.79 |
chr4_62612853_62613099 | 13.34 |
Rgs3 |
regulator of G-protein signaling 3 |
6544 |
0.18 |
chr13_18947816_18948472 | 13.34 |
Amph |
amphiphysin |
61 |
0.97 |
chr10_81233265_81233755 | 13.29 |
Zfr2 |
zinc finger RNA binding protein 2 |
323 |
0.7 |
chr3_35332947_35333329 | 13.19 |
Gm25442 |
predicted gene, 25442 |
7524 |
0.26 |
chr1_119033632_119034415 | 13.13 |
Gli2 |
GLI-Kruppel family member GLI2 |
19316 |
0.19 |
chr2_85198006_85198625 | 13.10 |
Lrrc55 |
leucine rich repeat containing 55 |
1118 |
0.31 |
chr11_24740164_24740317 | 13.10 |
Gm10466 |
predicted gene 10466 |
9518 |
0.27 |
chr2_112733041_112733261 | 13.09 |
Ryr3 |
ryanodine receptor 3 |
76603 |
0.1 |
chr7_51749421_51749572 | 13.08 |
Gm7336 |
predicted gene 7336 |
2849 |
0.25 |
chr5_147155070_147155280 | 13.03 |
Gsx1 |
GS homeobox 1 |
33521 |
0.11 |
chr5_111195506_111196004 | 13.02 |
Gm43676 |
predicted gene 43676 |
1385 |
0.43 |
chr1_10596534_10596685 | 12.99 |
Gm25253 |
predicted gene, 25253 |
40949 |
0.15 |
chr4_65888333_65888871 | 12.89 |
Trim32 |
tripartite motif-containing 32 |
283353 |
0.01 |
chr4_110120761_110121239 | 12.85 |
Elavl4 |
ELAV like RNA binding protein 4 |
102148 |
0.07 |
chr1_81520769_81521201 | 12.82 |
Gm37210 |
predicted gene, 37210 |
1356 |
0.55 |
chr10_95619438_95619589 | 12.81 |
Gm33336 |
predicted gene, 33336 |
12726 |
0.13 |
chr11_68274100_68274260 | 12.78 |
Gm12305 |
predicted gene 12305 |
3301 |
0.28 |
chr10_33624125_33624337 | 12.75 |
Gm15939 |
predicted gene 15939 |
15 |
0.5 |
chr2_21010157_21010628 | 12.72 |
Gm13375 |
predicted gene 13375 |
41338 |
0.14 |
chr9_51766490_51766741 | 12.70 |
Arhgap20 |
Rho GTPase activating protein 20 |
955 |
0.65 |
chr13_84398867_84399154 | 12.68 |
Gm26927 |
predicted gene, 26927 |
58897 |
0.13 |
chr10_46045847_46046012 | 12.67 |
Gpx4-ps2 |
glutathione peroxidase 4, pseudogene 2 |
170624 |
0.03 |
chr4_31493049_31493252 | 12.66 |
Gm11922 |
predicted gene 11922 |
112678 |
0.07 |
chr1_20428787_20428938 | 12.66 |
Gm15795 |
predicted gene 15795 |
15948 |
0.17 |
chr3_68824497_68825036 | 12.62 |
Gm7270 |
predicted gene 7270 |
21313 |
0.12 |
chr2_136051128_136051415 | 12.61 |
Lamp5 |
lysosomal-associated membrane protein family, member 5 |
968 |
0.6 |
chr8_82004303_82004454 | 12.60 |
Inpp4b |
inositol polyphosphate-4-phosphatase, type II |
114059 |
0.06 |
chr10_70949541_70949751 | 12.53 |
Bicc1 |
BicC family RNA binding protein 1 |
1157 |
0.46 |
chr5_30107616_30108097 | 12.53 |
3110082J24Rik |
RIKEN cDNA 3110082J24 gene |
1770 |
0.22 |
chr5_149503867_149504073 | 12.53 |
Gm2566 |
predicted gene 2566 |
918 |
0.48 |
chr7_137906593_137906744 | 12.48 |
Gm5650 |
predicted gene 5650 |
155338 |
0.04 |
chr6_88973830_88973981 | 12.47 |
4933427D06Rik |
RIKEN cDNA 4933427D06 gene |
23222 |
0.15 |
chr16_21204017_21204813 | 12.43 |
Ephb3 |
Eph receptor B3 |
340 |
0.87 |
chr2_62047440_62047741 | 12.43 |
Slc4a10 |
solute carrier family 4, sodium bicarbonate cotransporter-like, member 10 |
945 |
0.69 |
chr1_126454784_126455062 | 12.41 |
Nckap5 |
NCK-associated protein 5 |
6467 |
0.33 |
chr1_118776552_118777195 | 12.41 |
Gm28467 |
predicted gene 28467 |
33263 |
0.18 |
chr5_125151891_125152362 | 12.32 |
Ncor2 |
nuclear receptor co-repressor 2 |
26927 |
0.18 |
chr3_63740267_63740465 | 12.30 |
Plch1 |
phospholipase C, eta 1 |
499 |
0.82 |
chr8_47240394_47240550 | 12.30 |
Stox2 |
storkhead box 2 |
1865 |
0.37 |
chr3_88238770_88239032 | 12.27 |
Gm3764 |
predicted gene 3764 |
10118 |
0.07 |
chr2_106149818_106150014 | 12.26 |
Dcdc5 |
doublecortin domain containing 5 |
72141 |
0.1 |
chr2_62807459_62807865 | 12.24 |
Gm13569 |
predicted gene 13569 |
1525 |
0.44 |
chr10_63978633_63979013 | 12.23 |
Gm10118 |
predicted gene 10118 |
51389 |
0.17 |
chr15_10746902_10747061 | 12.22 |
4930556M19Rik |
RIKEN cDNA 4930556M19 gene |
29130 |
0.16 |
chr12_67220769_67221068 | 12.21 |
Mdga2 |
MAM domain containing glycosylphosphatidylinositol anchor 2 |
124 |
0.98 |
chr15_61690452_61690789 | 12.20 |
D030024E09Rik |
RIKEN cDNA D030024E09 gene |
54564 |
0.16 |
chr13_18218637_18218978 | 12.19 |
Pou6f2 |
POU domain, class 6, transcription factor 2 |
32321 |
0.19 |
chr17_3611352_3611547 | 12.16 |
1700102H20Rik |
RIKEN cDNA 1700102H20 gene |
53580 |
0.12 |
chr1_25033779_25033975 | 12.16 |
Gm29414 |
predicted gene 29414 |
6645 |
0.21 |
chr7_131777872_131778108 | 12.14 |
Gm44547 |
predicted gene 44547 |
8589 |
0.22 |
chr11_44977646_44977797 | 12.13 |
Ebf1 |
early B cell factor 1 |
65583 |
0.13 |
chr5_46572933_46573088 | 12.10 |
Gm43093 |
predicted gene 43093 |
70881 |
0.13 |
chr12_45562730_45563119 | 12.10 |
Gm48517 |
predicted gene, 48517 |
10363 |
0.27 |
chr11_60385103_60385422 | 12.09 |
Atpaf2 |
ATP synthase mitochondrial F1 complex assembly factor 2 |
31756 |
0.08 |
chr13_73034418_73035007 | 12.08 |
Rpl31-ps2 |
ribosomal protein L31, pseudogene 2 |
198683 |
0.02 |
chr9_92173926_92174156 | 12.06 |
Plscr5 |
phospholipid scramblase family, member 5 |
18895 |
0.21 |
chr5_37198021_37198718 | 12.06 |
Gm1043 |
predicted gene 1043 |
12472 |
0.19 |
chr9_40392395_40392598 | 12.05 |
Gramd1b |
GRAM domain containing 1B |
46 |
0.97 |
chr11_104155193_104155496 | 12.02 |
Crhr1 |
corticotropin releasing hormone receptor 1 |
22489 |
0.17 |
chr2_10373964_10374187 | 12.01 |
Gm13261 |
predicted gene 13261 |
34 |
0.89 |
chr18_37089713_37090118 | 12.01 |
Pcdhac1 |
protocadherin alpha subfamily C, 1 |
98 |
0.94 |
chr3_114508052_114508222 | 12.01 |
Gm43749 |
predicted gene 43749 |
36635 |
0.24 |
chr14_103649953_103650335 | 12.00 |
Slain1 |
SLAIN motif family, member 1 |
84 |
0.85 |
chr7_72738318_72738569 | 12.00 |
Gm7693 |
predicted gene 7693 |
24822 |
0.19 |
chr1_121226583_121227159 | 11.99 |
Gm29359 |
predicted gene 29359 |
2595 |
0.33 |
chr12_29526213_29526407 | 11.99 |
Myt1l |
myelin transcription factor 1-like |
2074 |
0.37 |
chr9_37453861_37454564 | 11.97 |
Robo3 |
roundabout guidance receptor 3 |
20966 |
0.1 |
chr2_135123767_135124325 | 11.96 |
4930545L23Rik |
RIKEN cDNA 4930545L23 gene |
91570 |
0.09 |
chr14_46885106_46885668 | 11.92 |
2810457G06Rik |
RIKEN cDNA 2810457G06 gene |
323 |
0.74 |
chr8_46210360_46210863 | 11.85 |
Slc25a4 |
solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 4 |
419 |
0.73 |
chr15_68650136_68650317 | 11.84 |
Gm25987 |
predicted gene, 25987 |
21190 |
0.19 |
chr6_45544302_45544926 | 11.84 |
Gm43876 |
predicted gene, 43876 |
15531 |
0.27 |
chr4_75855797_75855974 | 11.83 |
Gm11256 |
predicted gene 11256 |
1367 |
0.56 |
chr17_68490430_68490581 | 11.80 |
Gm15974 |
predicted gene 15974 |
118695 |
0.06 |
chr7_96832507_96832690 | 11.78 |
Gm44633 |
predicted gene 44633 |
14292 |
0.14 |
chr13_72298631_72298782 | 11.78 |
Gm4052 |
predicted gene 4052 |
51515 |
0.15 |
chr11_49931901_49932367 | 11.77 |
Rasgef1c |
RasGEF domain family, member 1C |
29973 |
0.14 |
chr3_21891883_21892491 | 11.77 |
7530428D23Rik |
RIKEN cDNA 7530428D23 gene |
91414 |
0.08 |
chr15_56278004_56278392 | 11.75 |
Hba-ps3 |
hemoglobin alpha, pseudogene 3 |
105809 |
0.07 |
chr19_24453375_24453543 | 11.75 |
Fam122a |
family with sequence similarity 122, member A |
23897 |
0.19 |
chr18_46360511_46360738 | 11.75 |
Gm4840 |
predicted gene 4840 |
3657 |
0.17 |
chr4_148399461_148399754 | 11.74 |
Gm13200 |
predicted gene 13200 |
40147 |
0.1 |
chr5_22452998_22453158 | 11.73 |
Gm43110 |
predicted gene 43110 |
19914 |
0.13 |
chr14_75455687_75456060 | 11.72 |
Siah3 |
siah E3 ubiquitin protein ligase family member 3 |
109 |
0.97 |
chr7_48778523_48778674 | 11.71 |
Zdhhc13 |
zinc finger, DHHC domain containing 13 |
10405 |
0.16 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.3 | 25.0 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
7.4 | 22.1 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
4.9 | 14.6 | GO:0072069 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
4.8 | 19.3 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
3.9 | 15.4 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
3.8 | 11.5 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
3.8 | 11.3 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
3.8 | 11.3 | GO:0010046 | response to mycotoxin(GO:0010046) |
3.5 | 7.1 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
3.5 | 10.4 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
3.4 | 13.7 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
3.3 | 16.6 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
3.3 | 13.2 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
3.1 | 6.3 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
3.1 | 3.1 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
3.0 | 20.8 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
2.8 | 11.1 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
2.8 | 8.3 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
2.8 | 8.3 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
2.7 | 10.8 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
2.7 | 8.1 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
2.6 | 10.3 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
2.5 | 7.6 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
2.4 | 7.3 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
2.4 | 19.3 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
2.4 | 7.2 | GO:0033505 | floor plate morphogenesis(GO:0033505) |
2.4 | 7.1 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
2.3 | 6.9 | GO:0060166 | olfactory pit development(GO:0060166) |
2.3 | 6.9 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
2.3 | 6.8 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
2.2 | 8.9 | GO:0007412 | axon target recognition(GO:0007412) |
2.1 | 4.3 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
2.1 | 10.7 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
2.1 | 8.5 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
2.1 | 6.3 | GO:0021570 | rhombomere 4 development(GO:0021570) |
2.1 | 8.3 | GO:0045794 | negative regulation of cell volume(GO:0045794) |
2.0 | 6.1 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
2.0 | 6.1 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
2.0 | 4.1 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) prostate gland morphogenetic growth(GO:0060737) |
2.0 | 10.1 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
2.0 | 4.0 | GO:0035262 | gonad morphogenesis(GO:0035262) |
1.9 | 9.6 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) |
1.9 | 3.8 | GO:0072092 | ureteric bud invasion(GO:0072092) |
1.9 | 11.4 | GO:0035989 | tendon development(GO:0035989) |
1.8 | 1.8 | GO:1902302 | regulation of potassium ion export(GO:1902302) |
1.8 | 1.8 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
1.8 | 3.7 | GO:1900368 | regulation of RNA interference(GO:1900368) |
1.8 | 14.3 | GO:0060539 | diaphragm development(GO:0060539) |
1.8 | 1.8 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
1.8 | 5.3 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
1.8 | 5.3 | GO:0060174 | limb bud formation(GO:0060174) |
1.8 | 15.8 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
1.7 | 5.2 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
1.7 | 5.2 | GO:0060594 | mammary gland specification(GO:0060594) |
1.7 | 5.2 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
1.7 | 5.1 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
1.7 | 5.1 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
1.7 | 32.3 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
1.7 | 3.4 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
1.7 | 5.1 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
1.7 | 13.5 | GO:2001054 | negative regulation of mesenchymal cell apoptotic process(GO:2001054) |
1.7 | 6.8 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
1.7 | 5.1 | GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
1.7 | 6.7 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
1.7 | 1.7 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
1.7 | 6.6 | GO:0007258 | JUN phosphorylation(GO:0007258) |
1.7 | 6.6 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
1.6 | 13.2 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
1.6 | 1.6 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
1.6 | 6.5 | GO:0071600 | otic vesicle morphogenesis(GO:0071600) |
1.6 | 1.6 | GO:0072173 | metanephric tubule morphogenesis(GO:0072173) |
1.6 | 4.8 | GO:0021856 | cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) facioacoustic ganglion development(GO:1903375) |
1.6 | 12.8 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
1.6 | 4.8 | GO:0097114 | NMDA glutamate receptor clustering(GO:0097114) |
1.6 | 1.6 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
1.6 | 3.1 | GO:0098596 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
1.6 | 4.7 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
1.6 | 12.4 | GO:0046069 | cGMP catabolic process(GO:0046069) |
1.5 | 4.6 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
1.5 | 4.6 | GO:2000437 | monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
1.5 | 7.7 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
1.5 | 4.6 | GO:0021553 | olfactory nerve development(GO:0021553) |
1.5 | 6.1 | GO:0061156 | pulmonary artery morphogenesis(GO:0061156) |
1.5 | 3.0 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
1.5 | 33.3 | GO:0035640 | exploration behavior(GO:0035640) |
1.5 | 10.5 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
1.5 | 7.5 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
1.5 | 6.0 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
1.5 | 1.5 | GO:1902913 | positive regulation of neuroepithelial cell differentiation(GO:1902913) |
1.5 | 4.4 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
1.5 | 2.9 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
1.4 | 5.7 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
1.4 | 5.7 | GO:0097152 | mesenchymal cell apoptotic process(GO:0097152) |
1.4 | 9.9 | GO:0042118 | endothelial cell activation(GO:0042118) |
1.4 | 4.2 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
1.4 | 4.2 | GO:0023041 | neuronal signal transduction(GO:0023041) |
1.4 | 12.5 | GO:0071371 | cellular response to gonadotropin stimulus(GO:0071371) |
1.4 | 5.5 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
1.3 | 4.0 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
1.3 | 4.0 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
1.3 | 5.4 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
1.3 | 4.0 | GO:0030070 | insulin processing(GO:0030070) |
1.3 | 1.3 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
1.3 | 12.0 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
1.3 | 12.0 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
1.3 | 5.3 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
1.3 | 1.3 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
1.3 | 5.2 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
1.3 | 3.9 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
1.3 | 18.1 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
1.3 | 6.5 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
1.3 | 15.3 | GO:0060134 | prepulse inhibition(GO:0060134) |
1.3 | 7.6 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
1.3 | 6.3 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
1.3 | 2.5 | GO:1902996 | neurofibrillary tangle assembly(GO:1902988) regulation of neurofibrillary tangle assembly(GO:1902996) |
1.3 | 6.3 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
1.2 | 3.7 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
1.2 | 3.7 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
1.2 | 12.4 | GO:0001964 | startle response(GO:0001964) |
1.2 | 2.5 | GO:0016198 | axon choice point recognition(GO:0016198) |
1.2 | 2.5 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
1.2 | 3.7 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
1.2 | 4.9 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
1.2 | 3.6 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
1.2 | 4.8 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
1.2 | 4.8 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
1.2 | 6.0 | GO:0071625 | vocalization behavior(GO:0071625) |
1.2 | 3.6 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
1.2 | 3.5 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
1.2 | 10.5 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
1.2 | 3.5 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
1.2 | 5.8 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
1.2 | 3.5 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
1.2 | 55.2 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
1.1 | 6.9 | GO:0097090 | presynaptic membrane organization(GO:0097090) |
1.1 | 3.4 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
1.1 | 3.4 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
1.1 | 9.1 | GO:0097120 | receptor localization to synapse(GO:0097120) |
1.1 | 3.4 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
1.1 | 22.5 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
1.1 | 9.0 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
1.1 | 1.1 | GO:0033058 | directional locomotion(GO:0033058) |
1.1 | 2.2 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
1.1 | 2.2 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
1.1 | 5.4 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
1.1 | 5.4 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
1.1 | 5.4 | GO:0022038 | corpus callosum development(GO:0022038) |
1.1 | 3.2 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
1.1 | 8.4 | GO:0071420 | cellular response to histamine(GO:0071420) |
1.0 | 3.1 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
1.0 | 3.1 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
1.0 | 1.0 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
1.0 | 4.0 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
1.0 | 1.0 | GO:0008050 | female courtship behavior(GO:0008050) |
1.0 | 2.0 | GO:1990123 | L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
1.0 | 5.9 | GO:0021559 | trigeminal nerve development(GO:0021559) |
1.0 | 2.9 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
1.0 | 6.9 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
1.0 | 2.9 | GO:0007638 | mechanosensory behavior(GO:0007638) |
1.0 | 13.5 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
1.0 | 3.8 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
1.0 | 2.9 | GO:0030035 | microspike assembly(GO:0030035) |
0.9 | 2.8 | GO:0052422 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.9 | 0.9 | GO:2000611 | positive regulation of thyroid hormone generation(GO:2000611) |
0.9 | 2.8 | GO:0097503 | sialylation(GO:0097503) |
0.9 | 10.3 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.9 | 6.5 | GO:0006108 | malate metabolic process(GO:0006108) |
0.9 | 1.9 | GO:0090135 | actin filament branching(GO:0090135) |
0.9 | 1.8 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.9 | 0.9 | GO:0042706 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
0.9 | 0.9 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.9 | 4.5 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.9 | 2.7 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.9 | 2.7 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.9 | 6.2 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.9 | 2.7 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.9 | 1.8 | GO:0035912 | dorsal aorta development(GO:0035907) dorsal aorta morphogenesis(GO:0035912) |
0.9 | 5.3 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.9 | 3.5 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.9 | 0.9 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.9 | 1.8 | GO:0065001 | specification of axis polarity(GO:0065001) |
0.9 | 2.6 | GO:0021554 | optic nerve development(GO:0021554) |
0.9 | 1.8 | GO:0071910 | determination of liver left/right asymmetry(GO:0071910) |
0.9 | 2.6 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.9 | 1.7 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.9 | 2.6 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.9 | 3.4 | GO:0098828 | modulation of inhibitory postsynaptic potential(GO:0098828) |
0.9 | 4.3 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.8 | 1.7 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.8 | 1.7 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.8 | 4.2 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.8 | 1.6 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.8 | 2.4 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
0.8 | 1.6 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.8 | 1.6 | GO:0046959 | habituation(GO:0046959) |
0.8 | 2.4 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.8 | 1.6 | GO:0042428 | serotonin metabolic process(GO:0042428) |
0.8 | 7.9 | GO:0036120 | cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.8 | 2.4 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.8 | 0.8 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
0.8 | 3.1 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.8 | 4.6 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.8 | 2.3 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.7 | 1.5 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
0.7 | 3.7 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.7 | 3.7 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.7 | 4.4 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) |
0.7 | 3.6 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.7 | 9.5 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.7 | 9.3 | GO:0061162 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
0.7 | 0.7 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.7 | 2.8 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.7 | 1.4 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
0.7 | 0.7 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.7 | 5.0 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.7 | 4.2 | GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
0.7 | 2.1 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.7 | 0.7 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.7 | 0.7 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
0.7 | 3.4 | GO:1902804 | negative regulation of synaptic vesicle transport(GO:1902804) |
0.7 | 1.4 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.7 | 1.4 | GO:2001187 | positive regulation of CD8-positive, alpha-beta T cell activation(GO:2001187) |
0.7 | 10.2 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.7 | 0.7 | GO:0034350 | regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) |
0.7 | 51.1 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.7 | 2.0 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.7 | 0.7 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.7 | 2.0 | GO:0071440 | regulation of histone H3-K14 acetylation(GO:0071440) positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.7 | 1.3 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.7 | 1.3 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.7 | 1.3 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.7 | 3.9 | GO:0010715 | regulation of extracellular matrix disassembly(GO:0010715) |
0.7 | 3.3 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.7 | 2.0 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.7 | 1.3 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.7 | 3.3 | GO:0015808 | L-alanine transport(GO:0015808) |
0.7 | 5.9 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.7 | 3.3 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.6 | 2.6 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.6 | 1.3 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.6 | 2.5 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.6 | 1.9 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.6 | 4.4 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.6 | 1.9 | GO:1904587 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.6 | 1.3 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
0.6 | 1.9 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.6 | 3.1 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.6 | 1.9 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
0.6 | 1.9 | GO:0015889 | cobalamin transport(GO:0015889) |
0.6 | 17.2 | GO:0019228 | neuronal action potential(GO:0019228) |
0.6 | 1.2 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.6 | 8.0 | GO:0098743 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.6 | 1.2 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.6 | 1.8 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.6 | 1.8 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.6 | 1.2 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.6 | 2.4 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
0.6 | 4.8 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.6 | 2.4 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.6 | 1.8 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.6 | 3.0 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.6 | 2.9 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.6 | 4.1 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.6 | 1.7 | GO:0030647 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.6 | 1.7 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.6 | 1.7 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.6 | 0.6 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.6 | 1.1 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.6 | 1.1 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.6 | 1.7 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.6 | 0.6 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.6 | 8.5 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.6 | 10.1 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.6 | 1.1 | GO:0090383 | phagosome acidification(GO:0090383) |
0.6 | 8.4 | GO:0021513 | spinal cord dorsal/ventral patterning(GO:0021513) |
0.6 | 1.1 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.6 | 7.2 | GO:0045056 | transcytosis(GO:0045056) |
0.6 | 1.7 | GO:0010649 | regulation of cell communication by electrical coupling(GO:0010649) |
0.6 | 1.7 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.5 | 1.6 | GO:0034093 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.5 | 2.2 | GO:0070842 | aggresome assembly(GO:0070842) |
0.5 | 1.6 | GO:0070268 | cornification(GO:0070268) |
0.5 | 1.6 | GO:0035106 | operant conditioning(GO:0035106) |
0.5 | 0.5 | GO:1903748 | negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
0.5 | 2.1 | GO:0030091 | protein repair(GO:0030091) |
0.5 | 0.5 | GO:0061205 | paramesonephric duct development(GO:0061205) |
0.5 | 4.2 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.5 | 2.1 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.5 | 22.1 | GO:0021510 | spinal cord development(GO:0021510) |
0.5 | 2.1 | GO:0002584 | negative regulation of antigen processing and presentation(GO:0002578) negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.5 | 2.5 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.5 | 3.0 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.5 | 1.0 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.5 | 2.5 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.5 | 1.0 | GO:1902915 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.5 | 1.0 | GO:0009629 | response to gravity(GO:0009629) |
0.5 | 1.5 | GO:0072178 | nephric duct development(GO:0072176) nephric duct morphogenesis(GO:0072178) |
0.5 | 1.5 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.5 | 0.5 | GO:0086028 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.5 | 2.4 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.5 | 2.9 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.5 | 0.9 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.5 | 5.2 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.5 | 0.9 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
0.5 | 1.4 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.5 | 3.7 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.5 | 1.8 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.5 | 1.8 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.5 | 12.8 | GO:0008542 | visual learning(GO:0008542) |
0.5 | 1.8 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.5 | 0.5 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
0.5 | 2.3 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.4 | 1.3 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.4 | 0.9 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.4 | 0.9 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.4 | 6.6 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.4 | 2.2 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.4 | 0.9 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
0.4 | 6.6 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.4 | 1.3 | GO:0045341 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
0.4 | 1.3 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.4 | 1.7 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.4 | 1.3 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.4 | 1.7 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.4 | 3.0 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.4 | 0.9 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.4 | 1.3 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.4 | 0.8 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.4 | 4.2 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.4 | 2.1 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.4 | 0.8 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.4 | 3.4 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.4 | 2.1 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.4 | 2.9 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.4 | 1.2 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.4 | 0.4 | GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.4 | 1.2 | GO:0006562 | proline catabolic process(GO:0006562) |
0.4 | 3.7 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.4 | 1.2 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.4 | 0.8 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.4 | 0.4 | GO:0019230 | proprioception(GO:0019230) |
0.4 | 1.6 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.4 | 0.8 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.4 | 1.2 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.4 | 0.8 | GO:2001028 | positive regulation of endothelial cell chemotaxis(GO:2001028) |
0.4 | 4.7 | GO:0007616 | long-term memory(GO:0007616) |
0.4 | 3.1 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
0.4 | 0.4 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.4 | 1.2 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.4 | 0.4 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.4 | 1.1 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.4 | 3.0 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.4 | 0.8 | GO:0060431 | primary lung bud formation(GO:0060431) |
0.4 | 3.8 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.4 | 0.8 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.4 | 1.1 | GO:0007296 | vitellogenesis(GO:0007296) |
0.4 | 1.1 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.4 | 1.8 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.4 | 0.7 | GO:0071472 | cellular response to salt stress(GO:0071472) |
0.4 | 0.7 | GO:0032345 | negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) regulation of cortisol biosynthetic process(GO:2000064) negative regulation of cortisol biosynthetic process(GO:2000065) |
0.4 | 1.1 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.4 | 1.4 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.3 | 0.7 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.3 | 2.1 | GO:0042491 | auditory receptor cell differentiation(GO:0042491) |
0.3 | 0.7 | GO:0035973 | aggrephagy(GO:0035973) |
0.3 | 0.3 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
0.3 | 1.0 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.3 | 0.3 | GO:0061590 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.3 | 0.3 | GO:0008354 | germ cell migration(GO:0008354) |
0.3 | 0.7 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.3 | 1.0 | GO:0090382 | phagosome maturation(GO:0090382) |
0.3 | 1.0 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.3 | 2.0 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.3 | 0.7 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.3 | 1.0 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.3 | 0.3 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.3 | 1.7 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.3 | 0.3 | GO:1900625 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.3 | 1.3 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.3 | 0.7 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.3 | 0.6 | GO:0035137 | hindlimb morphogenesis(GO:0035137) |
0.3 | 3.2 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.3 | 1.3 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.3 | 2.9 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.3 | 0.3 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.3 | 1.6 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.3 | 0.6 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.3 | 1.9 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.3 | 0.3 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.3 | 0.9 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.3 | 0.3 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.3 | 0.3 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.3 | 2.5 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.3 | 0.6 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
0.3 | 0.6 | GO:0032278 | positive regulation of gonadotropin secretion(GO:0032278) |
0.3 | 0.3 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) |
0.3 | 8.6 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.3 | 1.8 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.3 | 0.3 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
0.3 | 3.6 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.3 | 0.9 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.3 | 2.7 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.3 | 0.3 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.3 | 0.6 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.3 | 0.6 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.3 | 0.6 | GO:1903679 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.3 | 0.6 | GO:0035315 | hair cell differentiation(GO:0035315) |
0.3 | 0.6 | GO:2000143 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.3 | 1.1 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.3 | 0.6 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.3 | 0.6 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.3 | 0.6 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.3 | 1.4 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.3 | 0.3 | GO:0060278 | regulation of ovulation(GO:0060278) |
0.3 | 3.7 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.3 | 0.8 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.3 | 2.2 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.3 | 1.1 | GO:0071435 | potassium ion export(GO:0071435) |
0.3 | 0.3 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.3 | 7.2 | GO:0034605 | cellular response to heat(GO:0034605) |
0.3 | 1.4 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.3 | 5.5 | GO:0007215 | glutamate receptor signaling pathway(GO:0007215) |
0.3 | 4.6 | GO:0071242 | cellular response to ammonium ion(GO:0071242) |
0.3 | 0.3 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.3 | 1.1 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.3 | 0.5 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.3 | 1.1 | GO:0061050 | regulation of cell growth involved in cardiac muscle cell development(GO:0061050) |
0.3 | 2.2 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
0.3 | 0.5 | GO:0019086 | late viral transcription(GO:0019086) |
0.3 | 0.5 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.3 | 0.5 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.3 | 0.5 | GO:0051182 | coenzyme transport(GO:0051182) |
0.3 | 1.0 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.3 | 3.7 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.3 | 3.4 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.3 | 1.0 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.3 | 0.5 | GO:0014745 | negative regulation of muscle adaptation(GO:0014745) |
0.3 | 0.5 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.3 | 0.5 | GO:0048239 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.3 | 0.5 | GO:0061439 | renal system vasculature morphogenesis(GO:0061438) kidney vasculature morphogenesis(GO:0061439) glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
0.3 | 0.3 | GO:1904180 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.3 | 1.0 | GO:1903011 | negative regulation of bone development(GO:1903011) |
0.3 | 2.8 | GO:0034389 | lipid particle organization(GO:0034389) |
0.3 | 1.3 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.3 | 0.8 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.3 | 0.8 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.2 | 2.0 | GO:0048302 | regulation of isotype switching to IgG isotypes(GO:0048302) |
0.2 | 0.5 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.2 | 1.0 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.2 | 0.2 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.2 | 0.5 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.2 | 0.7 | GO:0042078 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.2 | 1.5 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.2 | 3.4 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.2 | 0.5 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.2 | 0.5 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.2 | 1.5 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.2 | 0.2 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.2 | 1.2 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.2 | 2.6 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.2 | 0.7 | GO:1903795 | regulation of inorganic anion transmembrane transport(GO:1903795) positive regulation of inorganic anion transmembrane transport(GO:1903797) |
0.2 | 1.2 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.2 | 0.2 | GO:0060534 | trachea cartilage development(GO:0060534) |
0.2 | 0.7 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.2 | 0.9 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.2 | 0.2 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) |
0.2 | 0.2 | GO:0061549 | sympathetic ganglion development(GO:0061549) |
0.2 | 0.9 | GO:0060602 | branch elongation of an epithelium(GO:0060602) |
0.2 | 0.9 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.2 | 0.5 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.2 | 0.7 | GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
0.2 | 0.9 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.2 | 0.2 | GO:2000002 | negative regulation of DNA damage checkpoint(GO:2000002) |
0.2 | 0.7 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
0.2 | 0.2 | GO:0032349 | positive regulation of aldosterone metabolic process(GO:0032346) positive regulation of aldosterone biosynthetic process(GO:0032349) |
0.2 | 1.1 | GO:0061318 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.2 | 0.7 | GO:0030859 | polarized epithelial cell differentiation(GO:0030859) |
0.2 | 3.8 | GO:0003341 | cilium movement(GO:0003341) |
0.2 | 0.2 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.2 | 0.7 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
0.2 | 1.5 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.2 | 1.5 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.2 | 1.3 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.2 | 0.2 | GO:0030576 | Cajal body organization(GO:0030576) |
0.2 | 0.4 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.2 | 1.5 | GO:0006983 | ER overload response(GO:0006983) |
0.2 | 2.8 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
0.2 | 0.4 | GO:0015755 | fructose transport(GO:0015755) |
0.2 | 1.7 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.2 | 0.2 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.2 | 1.5 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.2 | 0.8 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.2 | 1.9 | GO:0007416 | synapse assembly(GO:0007416) |
0.2 | 4.8 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.2 | 2.5 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.2 | 0.6 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
0.2 | 0.6 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.2 | 1.8 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.2 | 1.4 | GO:0060914 | heart formation(GO:0060914) |
0.2 | 0.6 | GO:0070305 | response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
0.2 | 0.2 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.2 | 0.6 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.2 | 0.8 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.2 | 0.8 | GO:0051451 | myoblast migration(GO:0051451) |
0.2 | 0.8 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.2 | 1.2 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.2 | 0.2 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
0.2 | 0.6 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.2 | 0.8 | GO:0035733 | hepatic stellate cell activation(GO:0035733) |
0.2 | 0.6 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.2 | 0.4 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.2 | 0.8 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.2 | 0.6 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.2 | 2.1 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) |
0.2 | 1.0 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.2 | 1.9 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.2 | 0.4 | GO:0060005 | vestibular reflex(GO:0060005) |
0.2 | 0.6 | GO:0001927 | exocyst assembly(GO:0001927) |
0.2 | 2.3 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.2 | 2.3 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.2 | 0.4 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.2 | 2.6 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.2 | 0.6 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.2 | 0.4 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
0.2 | 0.7 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.2 | 0.2 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.2 | 0.4 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.2 | 0.2 | GO:0002894 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) positive regulation of type IIa hypersensitivity(GO:0001798) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) positive regulation of type II hypersensitivity(GO:0002894) |
0.2 | 0.4 | GO:0001710 | mesodermal cell fate commitment(GO:0001710) |
0.2 | 0.5 | GO:2000020 | positive regulation of male gonad development(GO:2000020) |
0.2 | 0.5 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.2 | 0.5 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.2 | 0.7 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.2 | 0.7 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.2 | 1.2 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.2 | 0.7 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.2 | 0.4 | GO:0071699 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.2 | 3.0 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
0.2 | 0.2 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
0.2 | 0.3 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.2 | 0.5 | GO:0045423 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.2 | 0.2 | GO:2000313 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.2 | 4.0 | GO:0048260 | positive regulation of receptor-mediated endocytosis(GO:0048260) |
0.2 | 0.2 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
0.2 | 0.2 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.2 | 0.9 | GO:0003157 | endocardium development(GO:0003157) |
0.2 | 0.3 | GO:0034756 | regulation of iron ion transport(GO:0034756) |
0.2 | 1.0 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.2 | 0.2 | GO:0033206 | meiotic cytokinesis(GO:0033206) |
0.2 | 0.3 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.2 | 0.7 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.2 | 0.3 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.2 | 0.5 | GO:0071732 | cellular response to nitric oxide(GO:0071732) |
0.2 | 1.0 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.2 | 0.5 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.2 | 0.6 | GO:0042048 | olfactory behavior(GO:0042048) |
0.2 | 1.8 | GO:0060008 | Sertoli cell differentiation(GO:0060008) |
0.2 | 2.7 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.2 | 0.6 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
0.2 | 0.2 | GO:0051665 | membrane raft localization(GO:0051665) |
0.2 | 0.2 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.2 | 8.2 | GO:0097485 | neuron projection guidance(GO:0097485) |
0.2 | 0.6 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.2 | 0.5 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.2 | 0.3 | GO:0000087 | mitotic M phase(GO:0000087) |
0.2 | 0.5 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.2 | 0.5 | GO:0009177 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
0.2 | 1.4 | GO:0051797 | regulation of hair follicle development(GO:0051797) |
0.2 | 0.3 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.1 | 0.1 | GO:2001279 | regulation of prostaglandin biosynthetic process(GO:0031392) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) |
0.1 | 0.3 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.1 | 0.7 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.1 | 0.6 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.1 | 0.3 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.1 | 0.6 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.1 | 0.6 | GO:0033216 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
0.1 | 1.0 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 1.0 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
0.1 | 0.4 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.1 | 0.1 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
0.1 | 0.6 | GO:0051697 | protein delipidation(GO:0051697) |
0.1 | 0.1 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
0.1 | 0.3 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.1 | 0.7 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
0.1 | 1.5 | GO:0009208 | pyrimidine ribonucleoside triphosphate metabolic process(GO:0009208) |
0.1 | 0.1 | GO:0032513 | regulation of protein phosphatase type 2B activity(GO:0032512) negative regulation of protein phosphatase type 2B activity(GO:0032513) |
0.1 | 1.2 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.1 | 0.4 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.1 | 0.7 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.1 | 0.3 | GO:1903207 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.1 | 0.7 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.1 | 1.1 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.1 | 1.1 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.1 | 0.5 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.1 | 0.1 | GO:0034238 | macrophage fusion(GO:0034238) |
0.1 | 0.1 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.1 | 0.3 | GO:0002568 | somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
0.1 | 0.8 | GO:0000459 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.1 | 1.4 | GO:0035879 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.1 | 0.4 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.1 | 1.4 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.1 | 0.1 | GO:1900044 | regulation of protein K63-linked ubiquitination(GO:1900044) |
0.1 | 0.7 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.1 | 0.6 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.1 | 0.8 | GO:0009253 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.1 | 0.8 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.1 | 0.5 | GO:0050812 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.1 | 0.4 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.1 | 0.5 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.1 | 0.1 | GO:0072071 | mesangial cell differentiation(GO:0072007) glomerular mesangial cell differentiation(GO:0072008) kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) pericyte cell differentiation(GO:1904238) |
0.1 | 0.5 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.1 | 1.8 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.1 | 0.1 | GO:0071316 | cellular response to nicotine(GO:0071316) |
0.1 | 0.5 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.1 | 0.4 | GO:0046909 | intermembrane transport(GO:0046909) |
0.1 | 0.2 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.1 | 0.4 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.1 | 1.1 | GO:1903861 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.1 | 0.1 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.1 | 0.1 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.1 | 0.4 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.1 | 2.5 | GO:0051058 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
0.1 | 0.4 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.1 | 0.4 | GO:0016553 | base conversion or substitution editing(GO:0016553) |
0.1 | 0.4 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.1 | 0.6 | GO:0071236 | cellular response to antibiotic(GO:0071236) |
0.1 | 0.3 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 0.6 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.8 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.1 | 0.6 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.1 | 0.7 | GO:0060736 | prostate gland growth(GO:0060736) |
0.1 | 0.2 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.1 | 0.6 | GO:0019364 | pyridine nucleotide catabolic process(GO:0019364) |
0.1 | 1.1 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 0.1 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.1 | 3.3 | GO:0006400 | tRNA modification(GO:0006400) |
0.1 | 0.3 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
0.1 | 0.1 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
0.1 | 0.4 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.1 | 0.4 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
0.1 | 3.2 | GO:0098840 | intraciliary transport(GO:0042073) protein transport along microtubule(GO:0098840) |
0.1 | 1.5 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.1 | 0.1 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) |
0.1 | 0.1 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.1 | 0.6 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.1 | 0.2 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.1 | 0.3 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 0.1 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.1 | 0.2 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.1 | 0.2 | GO:0033085 | negative regulation of T cell differentiation in thymus(GO:0033085) |
0.1 | 0.2 | GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.1 | 0.2 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.1 | 0.3 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.1 | 0.7 | GO:0071025 | RNA surveillance(GO:0071025) |
0.1 | 0.1 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.1 | 0.1 | GO:0010513 | positive regulation of phosphatidylinositol biosynthetic process(GO:0010513) |
0.1 | 0.3 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.1 | 1.0 | GO:0046677 | response to antibiotic(GO:0046677) |
0.1 | 0.3 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.1 | 0.1 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
0.1 | 2.4 | GO:0051705 | multi-organism behavior(GO:0051705) |
0.1 | 1.7 | GO:0042246 | tissue regeneration(GO:0042246) |
0.1 | 0.2 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.1 | 0.3 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.1 | 4.7 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.1 | 0.5 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.1 | 0.2 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.1 | 0.2 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.1 | 0.4 | GO:0071569 | protein ufmylation(GO:0071569) |
0.1 | 0.8 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.1 | 0.2 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.1 | 0.2 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.1 | 0.5 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.1 | 0.1 | GO:0090237 | regulation of arachidonic acid secretion(GO:0090237) |
0.1 | 0.1 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.1 | 0.3 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.1 | 0.2 | GO:0010934 | macrophage cytokine production(GO:0010934) |
0.1 | 1.1 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.1 | 0.6 | GO:0007135 | meiosis II(GO:0007135) |
0.1 | 0.1 | GO:0002905 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.1 | 0.2 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.1 | 0.1 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
0.1 | 0.3 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.1 | 0.5 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
0.1 | 0.6 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.1 | 1.3 | GO:0031648 | protein destabilization(GO:0031648) |
0.1 | 0.1 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.1 | 0.8 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.1 | 0.8 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.1 | 0.1 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.1 | 0.1 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.1 | 0.2 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.1 | 0.1 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.1 | 0.1 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.1 | 0.2 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.1 | 2.0 | GO:0002066 | columnar/cuboidal epithelial cell development(GO:0002066) |
0.1 | 0.3 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.1 | 0.1 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.1 | 0.3 | GO:0043383 | negative T cell selection(GO:0043383) |
0.1 | 0.2 | GO:1900620 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
0.1 | 0.1 | GO:0051126 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) negative regulation of actin nucleation(GO:0051126) |
0.1 | 0.3 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 1.5 | GO:0050905 | neuromuscular process(GO:0050905) |
0.1 | 0.1 | GO:0031296 | B cell costimulation(GO:0031296) |
0.1 | 0.3 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.1 | 0.1 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.1 | 0.7 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.1 | 1.9 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.1 | 0.1 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.1 | 0.1 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.1 | 0.1 | GO:0086027 | AV node cell action potential(GO:0086016) AV node cell to bundle of His cell signaling(GO:0086027) AV node cell to bundle of His cell communication(GO:0086067) |
0.1 | 0.4 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.1 | 0.1 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.1 | 0.1 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 0.2 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.1 | 0.1 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.1 | 0.2 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
0.1 | 0.1 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.1 | 0.3 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.1 | 0.1 | GO:0097283 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.1 | 0.1 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.1 | 0.6 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.1 | 0.1 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.1 | 0.2 | GO:0071684 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.1 | 0.2 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.1 | 0.1 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.1 | 0.2 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.1 | 0.2 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.0 | 0.0 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.0 | 0.1 | GO:0060926 | cardiac pacemaker cell differentiation(GO:0060920) cardiac pacemaker cell development(GO:0060926) |
0.0 | 0.1 | GO:0021794 | thalamus development(GO:0021794) |
0.0 | 0.1 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.0 | 0.1 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.0 | 0.0 | GO:0097435 | fibril organization(GO:0097435) |
0.0 | 0.2 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.0 | 1.0 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.0 | 1.9 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.4 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.0 | 0.0 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.0 | 0.0 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
0.0 | 2.9 | GO:0006836 | neurotransmitter transport(GO:0006836) |
0.0 | 0.1 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.0 | 0.3 | GO:2000780 | negative regulation of double-strand break repair(GO:2000780) |
0.0 | 0.0 | GO:0071107 | response to parathyroid hormone(GO:0071107) |
0.0 | 0.2 | GO:0042417 | dopamine metabolic process(GO:0042417) |
0.0 | 0.1 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.0 | 0.2 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.0 | 0.0 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
0.0 | 0.1 | GO:0038031 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.0 | 0.1 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.0 | 0.1 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.0 | 0.1 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.0 | 0.0 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.0 | 0.3 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.0 | 0.1 | GO:0014856 | skeletal muscle satellite cell proliferation(GO:0014841) regulation of skeletal muscle satellite cell proliferation(GO:0014842) skeletal muscle cell proliferation(GO:0014856) regulation of skeletal muscle cell proliferation(GO:0014857) |
0.0 | 0.1 | GO:0001757 | somite specification(GO:0001757) |
0.0 | 0.2 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.0 | 0.1 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.0 | 1.0 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.0 | 0.0 | GO:0071223 | response to lipoteichoic acid(GO:0070391) cellular response to lipoteichoic acid(GO:0071223) |
0.0 | 0.4 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.0 | 0.1 | GO:0060004 | reflex(GO:0060004) |
0.0 | 0.1 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.0 | 0.2 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.0 | 0.5 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.0 | 0.2 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.0 | 0.0 | GO:0038001 | paracrine signaling(GO:0038001) |
0.0 | 0.0 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.0 | 0.1 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.0 | 0.0 | GO:0034136 | negative regulation of toll-like receptor 2 signaling pathway(GO:0034136) |
0.0 | 0.0 | GO:0043970 | histone H3-K9 acetylation(GO:0043970) |
0.0 | 0.0 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.0 | 0.1 | GO:1901299 | negative regulation of hydrogen peroxide-mediated programmed cell death(GO:1901299) |
0.0 | 0.3 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.0 | 0.5 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.0 | 0.1 | GO:0060571 | morphogenesis of an epithelial fold(GO:0060571) |
0.0 | 0.2 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.0 | 0.1 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.0 | 0.0 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.0 | 0.0 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
0.0 | 0.1 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
0.0 | 0.1 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.0 | 0.1 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.0 | 0.2 | GO:2000772 | regulation of cellular senescence(GO:2000772) |
0.0 | 0.2 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.0 | 1.0 | GO:0048813 | dendrite morphogenesis(GO:0048813) |
0.0 | 0.1 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.0 | 0.4 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.0 | 0.0 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
0.0 | 0.0 | GO:0045112 | integrin biosynthetic process(GO:0045112) |
0.0 | 0.0 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.0 | 0.4 | GO:0007340 | acrosome reaction(GO:0007340) |
0.0 | 0.0 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.0 | 0.0 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.0 | 0.1 | GO:0044838 | cell quiescence(GO:0044838) |
0.0 | 0.0 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.0 | 0.0 | GO:0015705 | iodide transport(GO:0015705) |
0.0 | 0.1 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.0 | 0.0 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.0 | 0.0 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.0 | 0.1 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.0 | 0.0 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
0.0 | 0.0 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.0 | 0.0 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.0 | 0.2 | GO:0052695 | cellular glucuronidation(GO:0052695) |
0.0 | 0.0 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.1 | 12.3 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
3.0 | 6.1 | GO:1990635 | proximal dendrite(GO:1990635) |
2.9 | 29.4 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
2.9 | 11.6 | GO:0032437 | cuticular plate(GO:0032437) |
2.8 | 8.5 | GO:0097441 | basilar dendrite(GO:0097441) |
2.8 | 33.2 | GO:0043194 | axon initial segment(GO:0043194) |
2.7 | 26.8 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
2.2 | 6.7 | GO:1990812 | growth cone filopodium(GO:1990812) |
2.1 | 17.0 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
2.1 | 14.5 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
2.1 | 10.3 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
2.0 | 8.1 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
1.9 | 5.8 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
1.9 | 5.8 | GO:0005594 | collagen type IX trimer(GO:0005594) |
1.9 | 5.7 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
1.8 | 12.9 | GO:0032584 | growth cone membrane(GO:0032584) |
1.8 | 5.3 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
1.6 | 3.3 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
1.6 | 3.2 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
1.6 | 6.4 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
1.5 | 4.6 | GO:0033010 | paranodal junction(GO:0033010) |
1.5 | 3.1 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
1.5 | 7.3 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
1.5 | 8.7 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
1.4 | 11.4 | GO:0005883 | neurofilament(GO:0005883) |
1.4 | 5.6 | GO:0030891 | VCB complex(GO:0030891) |
1.4 | 4.1 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
1.4 | 6.9 | GO:0071547 | piP-body(GO:0071547) |
1.4 | 56.3 | GO:0042734 | presynaptic membrane(GO:0042734) |
1.3 | 2.6 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
1.3 | 15.6 | GO:0044292 | dendrite terminus(GO:0044292) |
1.3 | 3.8 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
1.2 | 8.7 | GO:0043083 | synaptic cleft(GO:0043083) |
1.2 | 6.2 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
1.2 | 10.8 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
1.1 | 37.2 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
1.1 | 4.5 | GO:0043198 | dendritic shaft(GO:0043198) |
1.1 | 6.7 | GO:0071986 | Ragulator complex(GO:0071986) |
1.1 | 6.5 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
1.1 | 12.8 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
1.0 | 4.9 | GO:0097433 | dense body(GO:0097433) |
1.0 | 1.0 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.9 | 9.4 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.9 | 9.4 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.9 | 8.2 | GO:0030673 | axolemma(GO:0030673) |
0.9 | 1.8 | GO:0008091 | spectrin(GO:0008091) |
0.9 | 3.6 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.9 | 14.4 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.9 | 6.2 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.8 | 3.4 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.8 | 1.6 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.8 | 4.0 | GO:0089701 | U2AF(GO:0089701) |
0.8 | 8.8 | GO:0032433 | filopodium tip(GO:0032433) |
0.8 | 13.5 | GO:0005614 | interstitial matrix(GO:0005614) |
0.8 | 4.7 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.8 | 6.9 | GO:0036156 | inner dynein arm(GO:0036156) |
0.8 | 3.1 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.7 | 15.5 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.7 | 16.8 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.7 | 2.1 | GO:0033269 | internode region of axon(GO:0033269) |
0.7 | 5.3 | GO:0097542 | ciliary tip(GO:0097542) |
0.6 | 3.2 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.6 | 11.9 | GO:0044295 | axonal growth cone(GO:0044295) |
0.6 | 1.9 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.6 | 5.9 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.6 | 5.8 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.5 | 6.0 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.5 | 4.9 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.5 | 7.6 | GO:0043196 | varicosity(GO:0043196) |
0.5 | 4.8 | GO:0032590 | dendrite membrane(GO:0032590) |
0.5 | 1.1 | GO:0030313 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.5 | 6.9 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.5 | 6.3 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.5 | 6.3 | GO:0031045 | dense core granule(GO:0031045) |
0.5 | 2.0 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.5 | 8.9 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.5 | 0.5 | GO:0044308 | axonal spine(GO:0044308) |
0.5 | 1.0 | GO:0072534 | perineuronal net(GO:0072534) |
0.5 | 2.9 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.5 | 5.3 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.5 | 1.9 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.5 | 22.9 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.5 | 1.4 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.4 | 11.0 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.4 | 3.5 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.4 | 1.7 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.4 | 0.4 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.4 | 4.2 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.4 | 6.9 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.4 | 40.6 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.4 | 2.0 | GO:0042629 | mast cell granule(GO:0042629) |
0.4 | 59.6 | GO:0060076 | excitatory synapse(GO:0060076) |
0.4 | 1.6 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.4 | 0.4 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.4 | 2.3 | GO:0005915 | zonula adherens(GO:0005915) |
0.4 | 1.1 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.4 | 22.1 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.4 | 5.5 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.4 | 3.6 | GO:0031932 | TORC2 complex(GO:0031932) |
0.3 | 1.4 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.3 | 2.7 | GO:0001520 | outer dense fiber(GO:0001520) |
0.3 | 1.0 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.3 | 2.3 | GO:0005688 | U6 snRNP(GO:0005688) |
0.3 | 2.7 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.3 | 1.0 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.3 | 1.0 | GO:0032280 | symmetric synapse(GO:0032280) |
0.3 | 3.0 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.3 | 0.6 | GO:0070552 | BRISC complex(GO:0070552) |
0.3 | 0.9 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.3 | 0.9 | GO:0097427 | microtubule bundle(GO:0097427) |
0.3 | 13.2 | GO:0005871 | kinesin complex(GO:0005871) |
0.3 | 0.9 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.3 | 1.5 | GO:0045180 | basal cortex(GO:0045180) |
0.3 | 1.2 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.3 | 0.6 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.3 | 0.3 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.3 | 0.8 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.3 | 3.1 | GO:0016580 | Sin3 complex(GO:0016580) |
0.3 | 2.1 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.3 | 3.8 | GO:0043205 | fibril(GO:0043205) |
0.3 | 0.8 | GO:0071437 | invadopodium(GO:0071437) |
0.2 | 0.7 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.2 | 22.8 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.2 | 0.7 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.2 | 5.0 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.2 | 16.5 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.2 | 0.9 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.2 | 0.7 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.2 | 0.7 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.2 | 1.7 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.2 | 1.7 | GO:0097060 | synaptic membrane(GO:0097060) |
0.2 | 15.3 | GO:0030426 | growth cone(GO:0030426) |
0.2 | 0.8 | GO:0097440 | apical dendrite(GO:0097440) |
0.2 | 1.4 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.2 | 0.8 | GO:0031429 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
0.2 | 0.8 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.2 | 0.4 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.2 | 1.2 | GO:0030008 | TRAPP complex(GO:0030008) |
0.2 | 0.4 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.2 | 0.2 | GO:0033268 | node of Ranvier(GO:0033268) |
0.2 | 2.4 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.2 | 0.9 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.2 | 0.5 | GO:0043511 | inhibin complex(GO:0043511) |
0.2 | 2.1 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.2 | 0.5 | GO:0071942 | XPC complex(GO:0071942) |
0.2 | 4.5 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.2 | 0.8 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.2 | 1.3 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.2 | 1.6 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.2 | 1.7 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.2 | 1.2 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.2 | 1.7 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 0.4 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.1 | 25.1 | GO:0045202 | synapse(GO:0045202) |
0.1 | 0.4 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.1 | 0.4 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.1 | 1.2 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.1 | 0.5 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.1 | 0.5 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.1 | 6.2 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.1 | 0.4 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.1 | 0.2 | GO:0097413 | Lewy body(GO:0097413) |
0.1 | 0.2 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 0.3 | GO:0034706 | sodium channel complex(GO:0034706) |
0.1 | 0.5 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.1 | 1.3 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 0.3 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.1 | 0.7 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 1.2 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.1 | 1.0 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 0.4 | GO:1990462 | omegasome(GO:1990462) |
0.1 | 0.2 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.1 | 0.5 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 0.1 | GO:0032010 | phagolysosome(GO:0032010) |
0.1 | 0.7 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.1 | 0.1 | GO:0005767 | secondary lysosome(GO:0005767) |
0.1 | 0.3 | GO:0035339 | SPOTS complex(GO:0035339) |
0.1 | 0.2 | GO:0005955 | calcineurin complex(GO:0005955) |
0.1 | 1.5 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 0.7 | GO:0035102 | PRC1 complex(GO:0035102) |
0.1 | 2.8 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.2 | GO:0042585 | germinal vesicle(GO:0042585) |
0.1 | 2.5 | GO:0015935 | small ribosomal subunit(GO:0015935) |
0.1 | 2.6 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 0.4 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.0 | 0.3 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.0 | 1.8 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.0 | 0.3 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.4 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 0.1 | GO:0000802 | transverse filament(GO:0000802) |
0.0 | 0.1 | GO:0035061 | interchromatin granule(GO:0035061) |
0.0 | 0.1 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.0 | 0.1 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 0.2 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.0 | 0.5 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.0 | 0.0 | GO:0044453 | nuclear membrane part(GO:0044453) |
0.0 | 0.0 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.0 | 0.2 | GO:0070187 | telosome(GO:0070187) |
0.0 | 0.0 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
0.0 | 0.1 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.0 | 0.2 | GO:0018995 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
0.0 | 0.2 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.0 | 0.1 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.0 | 0.3 | GO:0005686 | U2 snRNP(GO:0005686) |
0.0 | 0.1 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.0 | 0.0 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.0 | 0.1 | GO:0000788 | nuclear nucleosome(GO:0000788) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.8 | 26.5 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
8.2 | 41.2 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
5.3 | 16.0 | GO:0070699 | type II activin receptor binding(GO:0070699) |
3.9 | 15.8 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
3.9 | 27.1 | GO:0003680 | AT DNA binding(GO:0003680) |
3.9 | 19.3 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
3.7 | 18.7 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
3.7 | 11.0 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
3.6 | 10.8 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
3.6 | 25.1 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
3.3 | 9.8 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
2.7 | 13.6 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
2.7 | 10.8 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
2.6 | 10.5 | GO:0032051 | clathrin light chain binding(GO:0032051) |
2.6 | 10.2 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
2.4 | 14.5 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
2.4 | 7.2 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
2.4 | 7.2 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
2.3 | 6.8 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
2.1 | 4.2 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
2.1 | 6.3 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
2.1 | 6.3 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
2.0 | 6.0 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
2.0 | 6.0 | GO:0045503 | dynein light chain binding(GO:0045503) |
2.0 | 17.7 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
1.9 | 5.8 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
1.8 | 11.0 | GO:0048495 | Roundabout binding(GO:0048495) |
1.8 | 12.5 | GO:0004385 | guanylate kinase activity(GO:0004385) |
1.7 | 5.1 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
1.6 | 8.0 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
1.6 | 3.2 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
1.6 | 4.7 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
1.5 | 3.0 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
1.4 | 4.1 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
1.4 | 5.5 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
1.3 | 15.6 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
1.3 | 3.9 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
1.3 | 28.0 | GO:0004120 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
1.3 | 3.8 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
1.2 | 6.2 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
1.2 | 6.1 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
1.2 | 15.5 | GO:0031005 | filamin binding(GO:0031005) |
1.2 | 5.9 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
1.2 | 3.6 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
1.2 | 3.6 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
1.2 | 8.3 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
1.2 | 2.3 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
1.2 | 5.8 | GO:0042609 | CD4 receptor binding(GO:0042609) |
1.2 | 3.5 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
1.2 | 2.3 | GO:0019959 | interleukin-8 binding(GO:0019959) |
1.1 | 9.1 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
1.1 | 4.5 | GO:0038064 | collagen receptor activity(GO:0038064) |
1.1 | 5.5 | GO:0001515 | opioid peptide activity(GO:0001515) |
1.1 | 18.3 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
1.1 | 4.2 | GO:0034056 | estrogen response element binding(GO:0034056) |
1.1 | 5.3 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
1.0 | 7.1 | GO:0043495 | protein anchor(GO:0043495) |
1.0 | 3.0 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
1.0 | 3.0 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
1.0 | 3.9 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.9 | 1.9 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.9 | 8.5 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.9 | 5.5 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.9 | 2.7 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.9 | 3.5 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.9 | 7.9 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.9 | 5.2 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.9 | 0.9 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.9 | 2.6 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.9 | 2.6 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.9 | 6.8 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.8 | 26.2 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.8 | 2.4 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.8 | 17.8 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.8 | 4.7 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.8 | 2.3 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.8 | 2.3 | GO:0008495 | 4-hydroxybenzoate octaprenyltransferase activity(GO:0008412) protoheme IX farnesyltransferase activity(GO:0008495) (S)-2,3-di-O-geranylgeranylglyceryl phosphate synthase activity(GO:0043888) cadaverine aminopropyltransferase activity(GO:0043918) agmatine aminopropyltransferase activity(GO:0043919) 1,4-dihydroxy-2-naphthoate octaprenyltransferase activity(GO:0046428) trans-pentaprenyltranstransferase activity(GO:0048045) ATP dimethylallyltransferase activity(GO:0052622) ADP dimethylallyltransferase activity(GO:0052623) |
0.8 | 0.8 | GO:0003896 | DNA primase activity(GO:0003896) |
0.7 | 2.2 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.7 | 15.3 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.7 | 0.7 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.7 | 2.1 | GO:0001031 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.7 | 0.7 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.7 | 2.8 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.7 | 1.4 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.7 | 2.8 | GO:0034584 | piRNA binding(GO:0034584) |
0.7 | 16.5 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.7 | 2.7 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.7 | 3.4 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.7 | 2.7 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.7 | 4.0 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.7 | 0.7 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.7 | 8.5 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.7 | 2.6 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.7 | 3.9 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.6 | 4.5 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.6 | 1.9 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.6 | 3.8 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.6 | 2.5 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.6 | 2.5 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.6 | 1.2 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.6 | 2.4 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.6 | 1.8 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.6 | 8.5 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.6 | 10.6 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.6 | 10.9 | GO:0016917 | GABA receptor activity(GO:0016917) |
0.6 | 3.9 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.6 | 7.8 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.5 | 3.3 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.5 | 3.3 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.5 | 2.6 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.5 | 2.6 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.5 | 2.1 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.5 | 1.6 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.5 | 1.5 | GO:0035939 | microsatellite binding(GO:0035939) |
0.5 | 2.6 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.5 | 1.0 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.5 | 1.5 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.5 | 1.5 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.5 | 1.0 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.5 | 4.5 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.5 | 1.5 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.5 | 1.5 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.5 | 1.5 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.5 | 3.5 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.5 | 4.4 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.5 | 3.9 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.5 | 1.9 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.5 | 3.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.5 | 1.9 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.5 | 4.2 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.5 | 6.1 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.5 | 1.4 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.5 | 1.8 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.5 | 1.4 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.5 | 1.4 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.5 | 2.7 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.4 | 9.0 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.4 | 5.4 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.4 | 0.4 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.4 | 5.7 | GO:0030506 | ankyrin binding(GO:0030506) |
0.4 | 1.3 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.4 | 3.0 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.4 | 6.5 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.4 | 8.2 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.4 | 4.7 | GO:0005522 | profilin binding(GO:0005522) |
0.4 | 14.9 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) heparan sulfate 2-O-sulfotransferase activity(GO:0004394) HNK-1 sulfotransferase activity(GO:0016232) heparan sulfate 6-O-sulfotransferase activity(GO:0017095) trans-9R,10R-dihydrodiolphenanthrene sulfotransferase activity(GO:0018721) 1-phenanthrol sulfotransferase activity(GO:0018722) 3-phenanthrol sulfotransferase activity(GO:0018723) 4-phenanthrol sulfotransferase activity(GO:0018724) trans-3,4-dihydrodiolphenanthrene sulfotransferase activity(GO:0018725) 9-phenanthrol sulfotransferase activity(GO:0018726) 2-phenanthrol sulfotransferase activity(GO:0018727) phenanthrol sulfotransferase activity(GO:0019111) 1-hydroxypyrene sulfotransferase activity(GO:0034930) proteoglycan sulfotransferase activity(GO:0050698) cholesterol sulfotransferase activity(GO:0051922) hydroxyjasmonate sulfotransferase activity(GO:0080131) |
0.4 | 4.7 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.4 | 11.8 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.4 | 0.8 | GO:0043199 | sulfate binding(GO:0043199) |
0.4 | 3.8 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.4 | 13.8 | GO:0019894 | kinesin binding(GO:0019894) |
0.4 | 2.5 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.4 | 1.2 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.4 | 1.6 | GO:0070052 | collagen V binding(GO:0070052) |
0.4 | 9.1 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.4 | 1.2 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.4 | 1.6 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.4 | 6.6 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.4 | 2.3 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.4 | 1.2 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.4 | 9.9 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.4 | 1.5 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.4 | 0.8 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.4 | 1.1 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.4 | 2.6 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.4 | 0.7 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.4 | 2.2 | GO:0031419 | cobalamin binding(GO:0031419) |
0.4 | 1.5 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.4 | 1.5 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.4 | 2.9 | GO:1901567 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.4 | 0.4 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
0.4 | 0.7 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.4 | 1.1 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.4 | 3.9 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.3 | 0.7 | GO:0034810 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.3 | 1.4 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.3 | 1.4 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.3 | 2.7 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.3 | 0.7 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.3 | 1.0 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.3 | 1.3 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.3 | 1.0 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.3 | 1.3 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.3 | 15.0 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.3 | 4.3 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.3 | 1.0 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.3 | 1.0 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.3 | 0.7 | GO:0030957 | Tat protein binding(GO:0030957) |
0.3 | 1.3 | GO:0043121 | neurotrophin binding(GO:0043121) |
0.3 | 1.0 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.3 | 0.6 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.3 | 3.5 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.3 | 0.3 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.3 | 1.5 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.3 | 10.4 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.3 | 8.2 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.3 | 0.9 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.3 | 2.7 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.3 | 3.0 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.3 | 5.6 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.3 | 13.2 | GO:0043621 | protein self-association(GO:0043621) |
0.3 | 2.3 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.3 | 0.9 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.3 | 1.2 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.3 | 1.5 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.3 | 1.2 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.3 | 3.7 | GO:0070628 | proteasome binding(GO:0070628) |
0.3 | 0.6 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.3 | 0.3 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.3 | 1.4 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.3 | 0.6 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.3 | 0.6 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.3 | 0.8 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.3 | 0.3 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) |
0.3 | 1.1 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.3 | 2.6 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.3 | 4.4 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.3 | 2.9 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.3 | 2.6 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.3 | 0.5 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.3 | 1.8 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.3 | 4.1 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.3 | 58.5 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.3 | 0.8 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.3 | 4.3 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.3 | 0.8 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.3 | 0.8 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.3 | 0.5 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.3 | 2.0 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.2 | 1.0 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.2 | 2.4 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.2 | 0.7 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.2 | 0.5 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.2 | 3.1 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.2 | 0.5 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.2 | 1.0 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.2 | 0.7 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.2 | 0.7 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.2 | 0.7 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.2 | 2.4 | GO:0015386 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.2 | 0.2 | GO:0004629 | phospholipase C activity(GO:0004629) |
0.2 | 0.9 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.2 | 1.3 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.2 | 3.5 | GO:0005112 | Notch binding(GO:0005112) |
0.2 | 0.4 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.2 | 0.9 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.2 | 0.7 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.2 | 0.4 | GO:0097016 | L27 domain binding(GO:0097016) |
0.2 | 5.2 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.2 | 2.8 | GO:0070402 | NADPH binding(GO:0070402) |
0.2 | 1.3 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.2 | 1.5 | GO:0039706 | co-receptor binding(GO:0039706) |
0.2 | 0.2 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.2 | 0.8 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.2 | 0.2 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.2 | 0.8 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.2 | 0.4 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.2 | 1.0 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.2 | 4.0 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.2 | 0.6 | GO:0034562 | mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.2 | 0.6 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.2 | 2.4 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.2 | 2.0 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.2 | 3.7 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.2 | 1.7 | GO:0034942 | 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.2 | 0.2 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.2 | 3.8 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.2 | 2.0 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.2 | 0.2 | GO:0005113 | patched binding(GO:0005113) |
0.2 | 0.5 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.2 | 1.3 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.2 | 2.5 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.2 | 0.9 | GO:0002054 | nucleobase binding(GO:0002054) |
0.2 | 2.5 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.2 | 1.4 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.2 | 0.3 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.2 | 0.7 | GO:0004952 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) dopamine neurotransmitter receptor activity(GO:0004952) |
0.2 | 1.8 | GO:0019203 | carbohydrate phosphatase activity(GO:0019203) |
0.2 | 0.3 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.2 | 2.3 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.2 | 0.3 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.2 | 0.8 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.2 | 0.5 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.2 | 3.0 | GO:0003785 | actin monomer binding(GO:0003785) |
0.2 | 0.8 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.1 | 0.9 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 0.7 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.1 | 0.6 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.1 | 2.8 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 0.1 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.1 | 2.0 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.1 | 0.4 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.1 | 1.0 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 0.7 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.1 | 0.4 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.1 | 1.3 | GO:0051378 | serotonin binding(GO:0051378) |
0.1 | 2.6 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 0.8 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.1 | 0.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 0.5 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 0.5 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.1 | 1.6 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.1 | 0.6 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 1.6 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 0.4 | GO:0015154 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.1 | 3.8 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.1 | 0.9 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 1.5 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.1 | 2.5 | GO:0032867 | C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity(GO:0000252) mevaldate reductase activity(GO:0004495) gluconate dehydrogenase activity(GO:0008875) epoxide dehydrogenase activity(GO:0018451) 5-exo-hydroxycamphor dehydrogenase activity(GO:0018452) 2-hydroxytetrahydrofuran dehydrogenase activity(GO:0018453) acetoin dehydrogenase activity(GO:0019152) phenylcoumaran benzylic ether reductase activity(GO:0032442) D-xylose:NADP reductase activity(GO:0032866) L-arabinose:NADP reductase activity(GO:0032867) D-arabinitol dehydrogenase, D-ribulose forming (NADP+) activity(GO:0033709) (R)-(-)-1,2,3,4-tetrahydronaphthol dehydrogenase activity(GO:0034831) 3-hydroxymenthone dehydrogenase activity(GO:0034840) very long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0035380) (R)-2-hydroxyisocaproate dehydrogenase activity(GO:0043713) L-arabinose 1-dehydrogenase (NADP+) activity(GO:0044103) L-xylulose reductase (NAD+) activity(GO:0044105) 3-ketoglucose-reductase activity(GO:0048258) D-arabinitol dehydrogenase, D-xylulose forming (NADP+) activity(GO:0052677) |
0.1 | 0.2 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.1 | 3.1 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.1 | 0.5 | GO:0022835 | transmitter-gated ion channel activity(GO:0022824) transmitter-gated channel activity(GO:0022835) |
0.1 | 0.6 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.1 | 0.7 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.1 | 0.4 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 0.1 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.1 | 0.6 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 0.4 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.1 | 1.0 | GO:0030955 | potassium ion binding(GO:0030955) |
0.1 | 0.5 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 0.6 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) intracellular cGMP activated cation channel activity(GO:0005223) |
0.1 | 0.6 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.2 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.1 | 0.2 | GO:0043515 | kinetochore binding(GO:0043515) |
0.1 | 0.5 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 2.6 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.1 | 2.3 | GO:0005504 | fatty acid binding(GO:0005504) |
0.1 | 1.9 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.1 | 0.7 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.1 | 0.3 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
0.1 | 0.4 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.1 | 0.3 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.1 | 0.7 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 0.2 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 2.0 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.1 | 6.5 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.1 | 0.5 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 0.2 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.1 | 1.4 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.1 | 1.5 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 0.2 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 0.7 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 0.2 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.1 | 0.1 | GO:0032356 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.1 | 1.8 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.1 | 1.1 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.1 | 0.2 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.1 | 0.8 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.1 | 0.1 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.1 | 2.7 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.1 | 0.3 | GO:0005217 | intracellular ligand-gated ion channel activity(GO:0005217) |
0.1 | 0.2 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.1 | 0.3 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) |
0.1 | 0.7 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.1 | 0.2 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.1 | 2.3 | GO:0008527 | taste receptor activity(GO:0008527) |
0.1 | 0.6 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.1 | 1.0 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.1 | 0.1 | GO:0035240 | dopamine binding(GO:0035240) |
0.1 | 0.1 | GO:0031402 | sodium ion binding(GO:0031402) |
0.1 | 0.5 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.1 | 0.2 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 0.2 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.1 | 0.4 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.1 | 0.1 | GO:0016595 | glutamate binding(GO:0016595) |
0.1 | 0.8 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 2.4 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.1 | 0.9 | GO:0045502 | dynein binding(GO:0045502) |
0.1 | 0.4 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.1 | 1.5 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.1 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.0 | 0.1 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
0.0 | 0.0 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) |
0.0 | 0.0 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.0 | 0.4 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.1 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.0 | 0.0 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.0 | 0.2 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.0 | 0.0 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.0 | 1.1 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.8 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 0.7 | GO:0030276 | clathrin binding(GO:0030276) |
0.0 | 0.2 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.0 | 0.1 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.0 | 0.1 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.0 | 0.4 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.0 | 0.3 | GO:0001618 | virus receptor activity(GO:0001618) |
0.0 | 0.0 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.0 | 0.1 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
0.0 | 0.4 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.6 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 0.1 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.0 | 0.1 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 0.1 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.0 | 0.1 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.0 | 0.1 | GO:0019808 | polyamine binding(GO:0019808) |
0.0 | 0.1 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.0 | 0.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.0 | 0.0 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.0 | 0.9 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 0.0 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.0 | 0.0 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.0 | 0.1 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.0 | 0.6 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.0 | 0.2 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.0 | 0.0 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.0 | 0.1 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.0 | 8.0 | GO:0005509 | calcium ion binding(GO:0005509) |
0.0 | 0.2 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.0 | 0.0 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.0 | 0.0 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.0 | 0.0 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.0 | 0.0 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.0 | 0.0 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.0 | 0.1 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.0 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.0 | 0.0 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 1.4 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
1.1 | 34.7 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
1.0 | 3.1 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.7 | 0.7 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.6 | 1.3 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.6 | 16.8 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.5 | 0.5 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.5 | 3.6 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.5 | 7.2 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.5 | 0.5 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.5 | 6.5 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.5 | 14.0 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.4 | 3.9 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.4 | 8.0 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.4 | 18.1 | NABA COLLAGENS | Genes encoding collagen proteins |
0.4 | 13.5 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.4 | 9.1 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.4 | 14.8 | PID SHP2 PATHWAY | SHP2 signaling |
0.4 | 6.5 | PID ARF 3PATHWAY | Arf1 pathway |
0.4 | 9.4 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.4 | 0.4 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.4 | 6.3 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.3 | 7.4 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.3 | 0.3 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.3 | 0.6 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.2 | 3.3 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.2 | 7.3 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.2 | 14.9 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.2 | 3.0 | ST ADRENERGIC | Adrenergic Pathway |
0.2 | 7.8 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.2 | 2.0 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.2 | 2.6 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.2 | 1.1 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.2 | 0.8 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.1 | 1.7 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 0.9 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 14.7 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 0.4 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 1.5 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 0.2 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 0.1 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 1.3 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 0.6 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 0.5 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.8 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.8 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 0.8 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 0.3 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.7 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 0.1 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 1.1 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 1.0 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.0 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 0.1 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 0.1 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 0.1 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 2.0 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.4 | 50.4 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
2.3 | 32.6 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
2.0 | 27.4 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
1.6 | 36.5 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
1.2 | 3.6 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
1.1 | 12.3 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
1.1 | 16.7 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
1.1 | 12.0 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
1.1 | 1.1 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
1.0 | 20.8 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.9 | 0.9 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.9 | 8.1 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.9 | 8.7 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.8 | 20.8 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.8 | 30.0 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.8 | 9.8 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.7 | 9.7 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.7 | 5.0 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.7 | 0.7 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.7 | 8.5 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.7 | 2.6 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.7 | 10.4 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.6 | 6.5 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.6 | 16.5 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.6 | 23.7 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.5 | 9.6 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.5 | 3.3 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.5 | 6.2 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.4 | 2.2 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.4 | 4.8 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.4 | 3.4 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.4 | 7.1 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.4 | 14.8 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.4 | 0.8 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.4 | 5.1 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.3 | 3.5 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.3 | 2.0 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.3 | 3.3 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.3 | 1.2 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.3 | 4.9 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.3 | 7.4 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.3 | 2.9 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.3 | 3.6 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.3 | 2.5 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.2 | 2.5 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.2 | 5.0 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.2 | 1.2 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.2 | 2.3 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.2 | 4.4 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.2 | 4.8 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.2 | 5.0 | REACTOME KINESINS | Genes involved in Kinesins |
0.2 | 0.2 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.2 | 1.3 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.2 | 2.3 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.2 | 0.4 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.2 | 3.6 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.2 | 1.3 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.2 | 3.4 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.2 | 3.0 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.2 | 0.2 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.2 | 2.1 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.2 | 1.7 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.2 | 0.5 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.2 | 1.7 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.2 | 0.5 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 6.7 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 1.4 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.1 | 0.6 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 2.0 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.1 | 1.8 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.1 | 0.9 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.1 | 0.1 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.1 | 1.0 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.1 | 1.2 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.1 | 1.5 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 0.7 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.1 | 0.2 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 1.3 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.1 | 1.0 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.1 | 0.3 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 1.9 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.1 | 1.1 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.1 | 1.7 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 1.4 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 0.5 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 0.2 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.1 | 12.3 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 0.8 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 2.7 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 0.2 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.1 | 0.6 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 0.5 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.0 | 0.5 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.0 | 0.2 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.0 | 0.4 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.0 | 0.8 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.0 | 0.4 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.0 | 0.0 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.0 | 0.0 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.0 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.0 | 0.0 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |